Literature DB >> 11703406

Fetal origins of adult disease?

R Morley1, T Dwyer.   

Abstract

1. Associations between lower birthweight and higher blood pressure, increased risk of type 2 diabetes and coronary heart disease (CHD) have been observed in a number of different populations worldwide. 2. The reason for this is still debated. Some believe that the observed associations can be explained on the basis of differences in postnatal growth, socioeconomic confounding or genetic factors. Two published studies of birthweight and CHD, with information on later size, suggest that both gestational and postnatal exposures are important. Associations between birthweight and blood pressure, seen in cohorts of twins treated as individuals, have generally remained when data are analysed within twin pairs. Furthermore, similar associations are seen in studies of animals with relative genetic homogeneity kept in standard conditions. These findings suggest that neither socioeconomic nor genetic factors are wholly responsible for the observed associations. 3. If then, there is an underlying causal association, two issues are of fundamental importance. First, is fetal growth (for which birthweight is a summary measure) involved in the causal pathway or is the causal factor a fetal exposure independently associated with fetal growth and increased risk of adult cardiovascular disease? The answer is important in terms of our understanding, the potential for intervention and estimation of the public health implications. Second, are the classic risk factors for CHD in the causal chain between fetal exposures or growth and adult CHD? Most prospective studies measure these factors, but their role as intermediates is unproven. 4. Intervention studies are the best way to test causal hypotheses, but our level of understanding is insufficient to justify such studies in humans, so we rely on animal studies to formally test causal hypotheses. In the present paper, we discuss design and statistical issues in relation to animal studies. The challenge in this field is to devise ways to identify and test potential causal hypotheses in humans.

Entities:  

Mesh:

Year:  2001        PMID: 11703406     DOI: 10.1046/j.1440-1681.2001.03557.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  9 in total

1.  Parental genotypes in the risk of a complex disease.

Authors:  Damian Labuda; Maja Krajinovic; Audrey Sabbagh; Claire Infante-Rivard; Daniel Sinnett
Journal:  Am J Hum Genet       Date:  2002-06-07       Impact factor: 11.025

Review 2.  Prospects for epigenetic epidemiology.

Authors:  Debra L Foley; Jeffrey M Craig; Ruth Morley; Craig A Olsson; Craig J Olsson; Terence Dwyer; Katherine Smith; Richard Saffery
Journal:  Am J Epidemiol       Date:  2009-01-12       Impact factor: 4.897

3.  Is birthweight associated with risk of rheumatoid arthritis? Data from a large cohort study.

Authors:  L A Mandl; K H Costenbader; J F Simard; E W Karlson
Journal:  Ann Rheum Dis       Date:  2008-07-01       Impact factor: 19.103

4.  Oligofructose supplementation (10%) during pregnancy and lactation does not change the inflammatory effect of concurrent trans fatty acid ingestion on 21-day-old offspring.

Authors:  Ana Claudia Losinskas Hachul; Laís Vales Mennitti; Juliana Lopes de Oliveira; Mayara Franzoi Moreno; Marcos Hiromu Okuda; Bruno Dos Santos; Lila Missae Oyama; Eliane Beraldi Ribeiro; Claudia Maria Oller do Nascimento; Luciana Pellegrini Pisani
Journal:  Lipids Health Dis       Date:  2013-05-01       Impact factor: 3.876

5.  Hydrogenated fat intake during pregnancy and lactation caused increase in TRAF-6 and reduced AdipoR1 in white adipose tissue, but not in muscle of 21 days old offspring rats.

Authors:  Juliana L de Oliveira; Lila M Oyama; Ana Cláudia L Hachul; Carolina Biz; Eliane B Ribeiro; Claudia M Oller do Nascimento; Luciana P Pisani
Journal:  Lipids Health Dis       Date:  2011-01-25       Impact factor: 3.876

6.  Maternal Supplementation with Oligofructose (10%) during Pregnancy and Lactation Leads to Increased Pro-Inflammatory Status of the 21-D-Old Offspring.

Authors:  Laís Vales Mennitti; Lila Missae Oyama; Juliana Lopez de Oliveira; Ana Claudia Losinskas Hachul; Aline Boveto Santamarina; Aline Alves de Santana; Marcos Hiromu Okuda; Eliane Beraldi Ribeiro; Claudia Maria da Penha Oller do Nascimento; Luciana Pellegrini Pisani
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

7.  Oligofructose supplementation during pregnancy and lactation impairs offspring development and alters the intestinal properties of 21-d-old pups.

Authors:  Laís Vales Mennitti; Lila Missae Oyama; Juliana Lopez de Oliveira; Ana Claudia Losinskas Hachul; Aline Boveto Santamarina; Aline Alves de Santana; Marcos Hiromu Okuda; Eliane Beraldi Ribeiro; Claudia Maria da Penha Oller do Nascimento; Luciana Pellegrini Pisani
Journal:  Lipids Health Dis       Date:  2014-02-05       Impact factor: 3.876

8.  Early exposure to distinct sources of lipids affects differently the development and hepatic inflammatory profiles of 21-day-old rat offspring.

Authors:  Laís Vales Mennitti; Lila Missae Oyama; Aline Boveto Santamarina; Claudia Maria da Penha Oller do Nascimento; Luciana Pellegrini Pisani
Journal:  J Inflamm Res       Date:  2018-01-18

9.  Hydrogenated fat diet intake during pregnancy and lactation modifies the PAI-1 gene expression in white adipose tissue of offspring in adult life.

Authors:  Luciana P Pisani; Claudia M Oller do Nascimento; Allain A Bueno; Carolina Biz; Kelse T Albuquerque; Eliane B Ribeiro; Lila M Oyama
Journal:  Lipids Health Dis       Date:  2008-04-04       Impact factor: 3.876

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.